Adatanserin
Izgled
(IUPAC) ime | |||
---|---|---|---|
N-[2-(4-pirimidin-2-ilpiperazin-1-il)etil]adamantan-1-karboksamid | |||
Klinički podaci | |||
Identifikatori | |||
CAS broj | 127266-56-2 | ||
ATC kod | nije dodeljen | ||
PubChem[1][2] | 130918 | ||
ChemSpider[3] | 115774 | ||
UNII | W5U6WQM26H | ||
Hemijski podaci | |||
Formula | C21H31N5O | ||
Mol. masa | 369,50 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status |
Adatanserin (WY-50,324, SEB-324) je mešoviti 5-HT1A receptor parcijalni agonist i antagonist 5-HT2A i 5-HT2C receptora.[4][5][6] On je razvijan kao kao antidepresiv ali je razboj zaustavljen.[6][7]
Adantaserin poseduje neuroprotektivna svojstva protiv ishemijom indukovane glutamatergičke ekscitotoksičnosti. Taj efekat je posredovan blokadom 5-HT2A receptora.[8]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.
- ↑ Singh A, Lucki I (April 1993). „Antidepressant-like activity of compounds with varying efficacy at 5-HT1A receptors”. Neuropharmacology 32 (4): 331–40. DOI:10.1016/0028-3908(93)90153-T. PMID 8497336.
- ↑ Kleven MS, Koek W (February 1996). „Pharmacological characterization of in vivo properties of putative mixed 5-HT1A agonist/5-HT2A/2C antagonist anxiolytics. I. Antipunishment effects in the pigeon”. The Journal of Pharmacology and Experimental Therapeutics 276 (2): 388–97. PMID 8632301.
- ↑ 6,0 6,1 Abou-Gharbia MA, Childers WE, Fletcher H, et al. (December 1999). „Synthesis and SAR of adatanserin: novel adamantyl aryl- and heteroarylpiperazines with dual serotonin 5-HT(1A) and 5-HT(2) activity as potential anxiolytic and antidepressant agents”. Journal of Medicinal Chemistry 42 (25): 5077–94. DOI:10.1021/jm9806704. PMID 10602693.
- ↑ Stahl, S. M. (2000). Essential psychopharmacology: neuroscientific basis and practical application. Cambridge, UK: Cambridge University Press. ISBN 0-521-64615-4.
- ↑ Dawson LA, Galandak J, Djali S (March 2002). „Attenuation of ischemic efflux of endogenous amino acids by the novel 5-HT(1A)/5-HT(2) receptor ligand adatanserin”. Neurochemistry International 40 (3): 203–9. DOI:10.1016/S0197-0186(01)00082-1. PMID 11741003.